Immatics at the Molecular Med TRI-CON Conference (Feb 15-16) in San Francisco, CA, USA

| News

We’re attending the Molecular Med TRI-CON Conference on February 15-16 in San Francisco. Steffen Walter, CSO Immatics US, talks at the Adoptive Cell-Based Cancer Immunotherapy symposium about multivalent Adoptive Cell Therapy using novel XPRESIDENT®-derived targets on Feb 16, 9am.

We're looking forward to interesting and exciting discussions. See the full agenda here:


Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.